BAY-320 is primarily utilized in the field of pharmaceutical research and development, particularly in the study of enzyme inhibition and receptor modulation. Its application is significant in the investigation of potential therapeutic agents for various diseases, including cancer and inflammatory conditions. Researchers employ BAY-320 to understand its interaction with specific biological targets, which aids in the design of more effective and selective drugs. Additionally, it serves as a valuable tool in preclinical studies to evaluate pharmacokinetics, pharmacodynamics, and safety profiles, contributing to the advancement of novel treatments in modern medicine.